您要查找的是不是：
- There is a acellular pertussis vaccine. 無細胞百日咳疫苗。
- tetanus, diphtheria & pertussis vaccine 破傷風、白喉和百日咳疫苗<生物製品>
- TPer/Vac(tetanus and pertussis vaccine) 破傷風和百日咳疫苗[生物製劑]
- Diphtheria Tetanus Pertussis and Poliomyeli-tis Vaccine 白喉-破傷風-百日咳-脊髓灰質炎菌苗[生物製劑]
- Pertussis vaccines -- are they safe and effective? 百日咳菌苗-它們是安全與有效的?
- diphtheria and tetanus toxoids and pertussis vaccine 白喉、破傷風類毒素、百日咳菌苗混合製劑, 百白破三聯製劑
- adsorbed diphtheria and tetanus toxoids and pertussis vaccine 吸附白喉、破傷風類毒素, 百日咳菌苗混合製劑, 吸附百白破三聯製劑
- adsorbed diphtheria, tetanus toxoid and pertussis vaccine 吸附白喉; 破傷風類毒素和百日咳菌苗混合製劑
- diphtheria and tetanus toxoids and pertussis vaccine, adsorbed 吸附白喉百日咳破傷風三聯菌苗, 吸附白百破三聯菌苗
- The infant receives three injections of pertussis vaccine at one-month intervals. 嬰兒以一個月為間隔，接受三次百日咳疫苗的注射。
- Conclusion The developed quality control method was suitable for the acellular pertussis vaccine in China. 結論所建立的質量控制方法可用於我國無細胞百日咳疫苗的質量控制。
- Most infants receive a pertussis vaccine, but its effectiveness subsides after about 10 years. 大多數嬰兒會接受百日咳疫苗的接種，但是在十年後效果會降低。
- The acellular pertussis vaccine manufactured by Lanzhou Institute of Biological Products was investigated for purity、toxicity and potency. 本文對無細胞百日咳菌苗的純度、免疫力和毒性進行了研究。
- Acellular pertussis vaccine recommended by WHO should contain five components: PT, FHA, PRN, FIM2 and FIM3, the major component is PT. FIM2和FIM3是百日咳桿菌的3種保護性抗原，在百日咳桿菌的致病和免疫過程中起重要作用。
- Objective In order to select the best preparation procedure of the national reference on toxicity of acellular pertussis vaccine. 目的篩選無細胞百日咳疫苗毒性國家參考品的最佳生產工藝。
- Objective To develop the methods for determination of component content and purity of acellular pertussis vaccine in China. 摘要目的建立我國無細胞百日咳疫苗組分含量和純度的檢測方法。
- Methods A mouse s point Houhai, point Zhongwan or abdominal cavity was injected with pertussis vaccine and its immune response was observed. 方法對小白鼠后海穴、中脘穴、腹腔注射百日咳疫苗觀察其免疫力。
- Bordetella pertussis toxin S1 mutant was successfully expressed and purified,which laid a molecular immunological foundation of developing candidate antigen of pertussis vaccine. 成功表達並純化了百日咳毒素S1亞單位突變體,為研製百日咳疫苗候補抗原的相關分子免疫學研究奠定了基礎。
- absorbed diphtheria, tetanus and pertussis vaccines 吸附百日咳菌苗; 白喉和破傷風類毒素混合製劑
- alum precipitated pertussis vaccine [醫] 明礬沉澱百日咳菌苗
